india is a growing vaccine hub explain in long answer
long deserve brainliest answer
Answers
Explanation:
How can a coronavirus vaccine be cleared for emergency use by millions of vulnerable people in a "clinical trial" mode?
No idea, says Dr Gagandeep Kang, one of India's best-known vaccine experts. "Either you are doing a clinical trial or not". Clinical trials - a three-phased process - determine whether the vaccine induces good immune responses and whether it causes any unacceptable side-effects.
On Sunday, India's drug regulator gave emergency approval of a locally produced coronavirus vaccine, called Covaxin, before the completion of trials. The government-backed vaccine has been developed by Bharat Biotech, a 24-year-old vaccine maker, which has a portfolio of 16 vaccines and exports to 123 countries.
The regulator said the vaccine had been approved for "restricted use in emergency situation in public interest as an abundant precaution, in clinical trial mode, especially in the context of infection by mutant strains". (The regulator also approved the global AstraZeneca Oxford jab, which is also being produced in India.)
This, despite the fact that the key third phase of Covaxin's clinical trials - the vaccine is given to thousands of people and tested for efficacy and safety - was underway.